Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
On the segmental front, the company's revenue from the sugar business stood at Rs 1,103.22 crore (down 14.98% YoY), distillery came in at Rs 289.05 crore (down 0.17% YoY), consumer products stood at Rs 143.03 crore (down 39.46%), crop protection was at Rs 1,098.29 crore (up 72.78% YoY), and nutrient and allied business was at Rs 7,761.77 crore (up 21.9% YoY) during the period under review.
On the other hand, the firm's income from nutraceuticals was at Rs 61.91 crore (up 44.25% YoY), and revenue from cogeneration stood at Rs 36.59 crore (down 10.36% YoY) in Q3 FY26.
Segment-wise, the farm inputs division continued to lead performance, recording a profit before interest and tax (PBIT) of Rs 741 crore for the quarter, up 3.35% from Rs 717 crore a year ago. Consolidated sugar operations, including refinery business, reported a loss before interest and tax of Rs 30 crore for the quarter ended 31st December 2025 as compared to a loss of Rs 59 crore in the corresponding quarter of the previous year.
The consolidated nutraceuticals division reported a loss before interest and tax of Rs 2 crore for the quarter ended 31st December 2025 as compared to Rs 5 crore in the corresponding quarter of the previous year.
EID Parry (India) is engaged in sugar, nutraceuticals, and ethanol production. It also has a significant presence in the farm inputs business, including biopesticides, through its subsidiary, Coromandel International.
Shares of EID Parry (India) rose 0.95% to Rs 990.45 on the BSE.
Powered by Capital Market - Live News